Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of unfractionated heparin injection in primary PCI for acute STEMI
IRCT20200510047380N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of heparin in myocardial infarction (MI) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: TIMI flow grade. Started May 2020; status: completed.
02
Drugs
heparin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20200510047380N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200510047380N1.